The Stromnes lab has defined cellular and epigenetic targets of immune checkpoint control of metastatic cancer to reveal targetable mechanisms and strategies to attack and treat immunotherapy-resistant cancer. 

Read the full publication: Science Immunology

Learn more: Press Release